ORMP
Price
$2.23
Change
-$0.04 (-1.76%)
Updated
Oct 17 closing price
Capitalization
91.44M
26 days until earnings call
Intraday Buy/Sell Signals
TYRA
Price
$14.50
Change
-$0.34 (-2.29%)
Updated
Oct 17 closing price
Capitalization
772.81M
11 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ORMP vs TYRA

Header iconORMP vs TYRA Comparison
Open Charts ORMP vs TYRABanner chart's image
Oramed Pharmaceuticals
Price$2.23
Change-$0.04 (-1.76%)
Volume$60.83K
Capitalization91.44M
Tyra Biosciences
Price$14.50
Change-$0.34 (-2.29%)
Volume$161.39K
Capitalization772.81M
ORMP vs TYRA Comparison Chart in %
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. TYRA commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and TYRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ORMP: $2.23 vs. TYRA: $14.50)
Brand notoriety: ORMP and TYRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 56% vs. TYRA: 79%
Market capitalization -- ORMP: $91.44M vs. TYRA: $772.81M
ORMP [@Biotechnology] is valued at $91.44M. TYRA’s [@Biotechnology] market capitalization is $772.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileTYRA’s FA Score has 1 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • TYRA’s FA Score: 1 green, 4 red.
According to our system of comparison, TYRA is a better buy in the long-term than ORMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 4 TA indicator(s) are bullish while TYRA’s TA Score has 5 bullish TA indicator(s).

  • ORMP’s TA Score: 4 bullish, 6 bearish.
  • TYRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TYRA is a better buy in the short-term than ORMP.

Price Growth

ORMP (@Biotechnology) experienced а -7.47% price change this week, while TYRA (@Biotechnology) price change was +7.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ORMP is expected to report earnings on Nov 14, 2025.

TYRA is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TYRA($773M) has a higher market cap than ORMP($91.4M). TYRA YTD gains are higher at: 4.317 vs. ORMP (-7.851). ORMP has higher annual earnings (EBITDA): -22.07M vs. TYRA (-121.07M). TYRA has more cash in the bank: 296M vs. ORMP (97.9M). ORMP has less debt than TYRA: ORMP (912K) vs TYRA (6.02M). ORMP has higher revenues than TYRA: ORMP (2M) vs TYRA (0).
ORMPTYRAORMP / TYRA
Capitalization91.4M773M12%
EBITDA-22.07M-121.07M18%
Gain YTD-7.8514.317-182%
P/E Ratio20.91N/A-
Revenue2M0-
Total Cash97.9M296M33%
Total Debt912K6.02M15%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
44
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPTYRA
RSI
ODDS (%)
Bearish Trend 3 days ago
65%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 11 days ago
84%
Declines
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TYRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQJPX11.550.08
+0.70%
GQG Partners Intl Qual Val Fd Inv
NWFAX35.550.22
+0.62%
Nationwide A
TDFIX8.550.04
+0.47%
Transamerica Sustainable Equity Inc I
YACKX25.250.11
+0.44%
AMG Yacktman I
GMNCX11.65-0.09
-0.77%
Gabelli Global Mini Mites C

TYRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TYRA has been loosely correlated with NUVL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TYRA jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TYRA
1D Price
Change %
TYRA100%
-2.29%
NUVL - TYRA
49%
Loosely correlated
+2.32%
NRIX - TYRA
46%
Loosely correlated
-1.89%
AURA - TYRA
45%
Loosely correlated
-8.40%
KYMR - TYRA
43%
Loosely correlated
-1.04%
RGNX - TYRA
42%
Loosely correlated
-4.94%
More